MDMA Reimbursement Conference Notes: 2019

MDMA Reimbursement Conference Notes 2019 - Top Takeaways from sessions at the Medical Device Manufacturers Association Healthcare Policy and Reimbursement Conference

Perspectives on Medical Reimbursement By JR Associates The Medical Device Manufacturers Association’s annual Coverage, Reimbursement and Health Policy Conference is always a high point on our firm’s schedule. That’s because our President, Judy Rosenbloom, and our VP of Global Health Policy, Jo Ellen Slurzberg, work hand-in-hand with MDMA each year to develop and deliver this educational event. Our relationship with…

Read More »

MDMA Reimbursement Conference Notes: 2018

MDMA Reimbursement Conference Notes 2018

Perspectives on Medical Reimbursement By JR Associates Among our consultants, the MDMA Coverage, Reimbursement and Health Policy Conference is more than just another event on the business calendar. For us, it is an important professional tradition that began 21 years ago. That’s when our President, Judy Rosenbloom, and VP of Global Health Policy, Jo Ellen…

Read More »

Bundled Payments: Implications for Medical Device & Drug/Biologic Companies

Bundled Payments for Medical Technology

Perspectives on Medical Reimbursement By JR Associates Recently, the trade press and mainstream news have been paying a lot of attention to bundled payments. Stories have focused primarily on how this shift in medical reimbursement will affect patients, providers and payers. Payers and provider networks are creating internal systems to identify the cost of treating…

Read More »